SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies - Summary - MDSpire

SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies

  • By

  • John W. Snelgrove

  • Rinku Sutradhar

  • Nancy N. Baxter

  • Karl Everett

  • Stephanie C. Lapinsky

  • Douglas M. Campbell

  • Mark H. Yudin

  • Howard Berger

  • Eliane M. Shore

  • Andrea N. Simpson

  • May 7, 2026

  • 0 min

Share

Objective:

To evaluate associations between laboratory-confirmed maternal SARS-CoV-2 infection during pregnancy and neonatal congenital anomalies in Ontario, Canada, with a focus on the implications for public health.

Key Findings:
  • No significant association found between maternal SARS-CoV-2 infection and overall neonatal congenital anomalies in a sample of X births.
  • Congenital cardiac anomalies were not significantly increased in infants born to mothers with SARS-CoV-2 infection.
  • Timing of maternal infection (trimester) did not show a clear link to congenital anomalies.
Interpretation:

The study suggests that maternal SARS-CoV-2 infection during pregnancy does not significantly increase the risk of congenital anomalies in newborns, which has important implications for public health.

Limitations:
  • Study limited to data from Ontario, which may not be generalizable to other regions.
  • Potential confounding factors not fully accounted for, such as maternal health conditions and unmeasured confounders.
Conclusion:

Further research is needed to explore the teratogenic effects of SARS-CoV-2, particularly focusing on timing and other maternal health factors, including socioeconomic status.

Original Source(s)

Related Content